GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HOB Biotech Group Corp Ltd (SHSE:688656) » Definitions » Price-to-Owner-Earnings

HOB Biotech Group (SHSE:688656) Price-to-Owner-Earnings : (As of Jun. 02, 2025)


View and export this data going back to 2021. Start your Free Trial

What is HOB Biotech Group Price-to-Owner-Earnings?

As of today (2025-06-02), HOB Biotech Group's share price is ¥95.83. HOB Biotech Group does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for HOB Biotech Group's Price-to-Owner-Earnings or its related term are showing as below:

During the past 9 years, the highest Price-to-Owner-Earnings of HOB Biotech Group was 88.87. The lowest was 66.50. And the median was 75.63.


SHSE:688656's Price-to-Owner-Earnings is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 27.99
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-06-02), HOB Biotech Group's share price is ¥95.83. HOB Biotech Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.55. Therefore, HOB Biotech Group's PE Ratio (TTM) for today is 174.24.

As of today (2025-06-02), HOB Biotech Group's share price is ¥95.83. HOB Biotech Group's EPS without NRI for the trailing twelve months (TTM) ended in was ¥0.57. Therefore, HOB Biotech Group's PE Ratio without NRI for today is 168.12.

During the past 9 years, HOB Biotech Group's highest PE Ratio without NRI was 243.34. The lowest was 24.59. And the median was 45.59.


HOB Biotech Group Price-to-Owner-Earnings Historical Data

The historical data trend for HOB Biotech Group's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HOB Biotech Group Price-to-Owner-Earnings Chart

HOB Biotech Group Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only - - - - -

HOB Biotech Group Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of HOB Biotech Group's Price-to-Owner-Earnings

For the Medical Devices subindustry, HOB Biotech Group's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HOB Biotech Group's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HOB Biotech Group's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where HOB Biotech Group's Price-to-Owner-Earnings falls into.


;
;

HOB Biotech Group Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

HOB Biotech Group's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=95.83/-2.04
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HOB Biotech Group  (SHSE:688656) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


HOB Biotech Group Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of HOB Biotech Group's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


HOB Biotech Group Business Description

Traded in Other Exchanges
N/A
Address
No. 218, Xinghu Street, Room 101, Building C6, Bio-Nano Park, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215009
HOB Biotech Group Corp Ltd is an in vitro diagnostic company. The firm is specialized in providing diagnostic tools to laboratories and hospitals for the improvement of allergy and autoimmune disease patient care.

HOB Biotech Group Headlines

No Headlines